5-(1-isopropyl-5-methyl-1H-pyrazol-3-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

2-Amino-3,5-dibromopyrazine, 97.0%, 10g

(2R)-2-Amino-2-phenylacetamide, 97.0%, 5g

6-Fluoro-1,2,3,4-tetrahydronaphthalen-2-amine, 97%, 50mg

5-(4-Fluorophenyl)thiophene-2-carboxylic acid, 97.0%, 1g

(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 95.0%, 100mg

ETHYL 2,4-DIHYDROXY-5,6-DIMETHYLNICOTINATE, 97.0%, 1g

[(2-methylphenyl)(4-pyridinyl)methyl]amine dihydrochloride, 95.0%, 5g

1-(4-Nitrophenyl)cyclobutanecarboxylic acid, 97.0%, 1g

(5-Bromopentyl)benzene>98.0%(GC)5g

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 1.00 µm, 1 Piece(s)

tert-Butyl 3-Methylenecyclobutylcarbamate, 95.0%, 5g

(3S,4S)-tert-Butyl 4-amino-3-methylpiperidine-1-carboxylate, 98%, 100mg